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ABSTRACT : Seventy-one patients with primary bronchogenic carcinoma Under-
went bronchoplastic procedures (48 sleeve lobectomies and 23 wedge resection) from 
1969 to 1986. In 16 patients the bronchoplasty with concomitant resection of pul-
monary artery was performed. There were 48 squamous cell carcinomass, 13 adeno-
carcinomas, six large cell and four small cell carcinomas. There was no nodal 
metastasis in 26 patients (36.6%), 27 patients (38.0%) had mediastinal nodes involve-
ment. Pathological stages of the disease were as follows : Stage I , one patients ; 
Stage II, 13 patients ; Stage III, 41 patients ; and Stage IV, one patient. Five year survi-
val rate was 25.4%. Survival rates on the basis of nodal involvement indicate 44.1% 
at five years for patients without nodal metastasis and 18.4% for those with nodal 
involvement. 
 Ten patients complained difficulty in expectoration after surgery, and frequent 
therapeutic bronchofiberscopy was necessary. Four patients had an early bronchial 
fistula. Bronchial stenosis or obstruction due to formation of suture granulation 
occurred in six patients, and local recurrence at bronchial suture line was observed 
in six patients. Three patients with resection of the pulmonary artery had vascular 
complications. In two patients obstruction of the pulmonary artery due to formation 
of thrombus occurred, and in one patient pulmonary artery was twisted. 
 Bronchoplastic procedure can be perfomed safely, but if angioplasty of the pul-
monary artery was concomitantly performed, it shoule be done carefully to prevent 
vascular distortion or stenosis. 
 Since the description of bronchoplastic procedures by Paulson and Shaw in 1955 
and Price Thomas in 1956, many reports have documented on the merits of these 
procedures. Sleeve lobectomy for lung cancer is an alternative to pneumonectomy, 
when the tumor extends into main bronchus. This operative procedure benifits the 
patients by conservation of lung tissues for whom pneumonectomy is not indicated 
because of poor pulmonary reserve. 
 This report summarized our 17 years' experience in lobectomy with bronchoplastic 
procedures and angioplasty of the pulmonary artery.
CLINICAL MATERIAL AND METHODS
 Seventy-one patients underwent bronchoplas-
tic procedures for lung cancer at Nagasaki Uni-
versity Hospital from January 1969 to October
1986. There were 62 males and nine females, 
with a mean age of 60.3 years. Among these 
patients, bronchoplasty with the pulmonary 
artery reconstruction was performed in 16 pati-
ents. 
 The cell types of lung cancer included squa-
mous cell carcinoma in 48 patients, representing 
67.6% of the entire series ; adenocarcinoma in 
13 patients (18.3%), large cell carcinoma in 
six patients (8.4%), and small cell carcinoma 
in four patients (5.6%). Among the patients 
undergoing pulmonary artery reconstruction, 
there were 11 patients (68.7%) with squamous 
cell carcinoma, three patients (18. 7 % ) with 
adenocarcinoma, and two patients ( 12.5 % ) 
with small cell carcinoma. 
 According to the postoperative TNM staging, 
there were 16 patients (22.5%) with Stage I 
cancer, 14 patients with Stage II cancer, and 41 
patients (57.7%) with Stage III disease. There 
were 29 patients in the Stage III group who had 
positive mediastinal lymph nodes. Among the 
patients undergoing pulmonary artery reconst-
ruction, there were two patients with Stage I 
and II cancer as well as 14 patients (87.5 % ) 
with Stage III cancer. The majority of the pati-
ents in the Stage II[ group included 10 patients 
with positive mediastinal lymph nodes (Table 
1). 
Table 1. Staging of Bronchoplasty for Lung 
        Cancer
                    No. of patients (%) 
  Stage Bronchoplasty Bronchoplasty+ 
                           PA-Reconstraction 
 I 16 (22.5) 1 ( 6.3) 
   T2NoMo 5 0
   T2NiMo 0 0
   TLNOMo 11 1
 II 13 (18.3) 1 ( 6.3) 
   T2NoMo 13 1
 Ilt 41 (57.7) 14 (87.5) 
   T3NoMo 9 2 
   T3N1Mo 3 2
ANY T N2MO 29 10 
 IV 1 0
 The site of carcinoma was right upper lobe 
in 35 patients. There were 24 sleeve lobectomy 
and 11 wedge procedures. Right middle and 
lower lobectomy was performed on 13 patients
; nine patients underwent sleeve lobectomy and 
four patients wedge resection. Left upper lobe 
sleeve resection was done in 13 patients, and 
left lower sleeve lobectomy in three patients. 
The majority of the sites of cancers in 16 pati-
ents undergoing bronchoplasty with concomi-
tant pulmonary artery reconstruction were left 
upper lobes. Sleeve resection of the pulmonary 
artery was conducted in 10 of the 11 left upper 
lobectomy cases and wedge resection was done 
in four of the five right upper lobectomy cases 
(Table 2)
Table 2. Site of Carcinoma in Patients Under-
       going Bronchoplasty 
                       Procedure 
   Site Bronchial Resection PA Resection 
               Sleeve Wedge Sleeve Wedge 
Right upper lobe 24 11 1 4 
Right middle 9 4 0 0 
   + lower lobe 
Left upper lobe 13 6 10 1 
Left lower lobe 3 1 0 0
 The patients undergoing bronchoplastic prose-
dures were selected by the bronchoscopic appea-
rance of the tumor, which extended to the lobar 
orifice and toward the mucosa of the adjacent 
main bronchus. When the tumor extended to 
the pulmonary artery, sleeve or wedged resec-
tion of the main artery was performed. Occa-
sionaly, bronchoplastic procedures were indi-
cated for the patient who had metastatic nodes 
invading to the main bronchus. 
 The technique of bronchoplastic procedure 
has been well documented. However, certain 
points deserve further emphasis. 
 Techniques of ventilation and anesthesia 
have undergone evolutionary change. We origi-
nally used the single lumen tube for broncho-
plastic procedure and atraumatic clamp or 
tampons to occlude the proximal main bronchus. 
Since the obstruction at the left main bronchus 
by the tumor migration had occurred in three 
patients in whom the single lumen tube was 
used for right sided bronchoplasty, we have 
recently used double lumen tube on the both 
sides, or an univent tube on the left side. 
 The suture material originally used for bron-
chial anastomosiswas 3- 0 Nylon. Long-term
follow-up of patients in whom Nylon was used 
revealed that the suture knots became covered 
with granulation tissues. We now perform the 
anastomosis with 3-0 coated polyglycolic suture. 
This material can be absorbed entirely, and we 
have yet to identify an excess of any associated 
granulation tissue formation. 
 The anastomosis is routinely covered by 
circumferential pleural flap that may prevent 
a bronchopleural fistula or bronchovascular 
fistula. 
 Routine postoperative bronchofiberscopy is 
done at bedside to remove any secretion at the 
anastomosis. 
          RESULT 
 The cumulative five-year survival rate among 
the 16 patients with Stage I disease was 46.7%, 
27.8% in the 13 patients with Stage II disease, 
and 26.1% in the 41 patients with Stage III can-
cer, while there were no one-year survivor in 
the Stage IV group (Fig. 1)
Fig. 2 Survival curves by nodal involvement 
  Five-year survival rate among the 48 patients 
with squamous cell carcinoma was 41.2%. 
Three-year survival rate was 20.3% in the 13 
patients with adenocarcinoma, and 16% in the 
six patients with large cell carcinoma. Further-
more, in small cell carcinoma there were no 
patients surviving over years. 
  Five-year survival rate in the patients receiv-
ing concomitant pulmonary artery reconstruct-
ion were 4 9. 1 %, which is a favorable result 
compared with results of our entire series (Fig. 
3)
Fig. 1 Survival curves by Stage of disease 
 No lymph node metastasis were found in 26 
patients. Among these patients, five-year survi-
val rate was 44.1%. The 45 patients with posi-
tive lymph nodes had five-year survival rate 
of 18.4% (Fig. 2)
Fig. 3 Survival curves of patients undergoing 
      bronchoplasty for lung cancer 
 The most common postoperative compli-
cation was difficulty in expectoration, which 
occurred in 10 patients (14.0%) and there were 
two cases of atelectasis. Routine postoperative 
bronchofiberscopy was conducted with the aim 
of preventing these complications. Granulation 
of the bronchial anastomosis was found in 11 
patients (8.4%) and severe stenosis in six (5.6 
%) patients. To deal with these complications,
the complete pneumonectomy was finally done 
in two cases, but as far as the absorbable 
suture is used, anastomotic granulation and 
stenosis were not yielded. Anastomotic deficien-
cy was observed in four cases (5.6%). Therefore 
pneumonectomy was attempted in one patient. 
Bronchovascular fistula was noted in three 
patient (4.2%). All three patients were suffo-
cated. Tumor recurrence at the bronchial ana-
stomosis was found in six patients (5.6%). The 
obstruction of the pulmonary artery at the 
anastomosis was found in three patients. In 
two of the three patients obstruction due to 
thrombus occurred on the 4th postoperative 
day and pneumonectomy was performed im-
mediately. In one of the three patients distor-
tion of the pulmonary artery occurred. 
 Eight patients who underwent sleeve lobec-
tomy with concomitant resection of pulmonary 
artery are still surviving and their period of 
observation ranged from one year and five 
months to 13 years. Three of these cases have 
demostrated tumor recurrence in the lung or 
bronchial anastomosis. In our series there were 
6 operative deaths (8.4%) : four patients under-
went bronchoplasty alone, and two patients, 
bronchoplastic procedure in combination with 
pulmonary angioplasty. However, these were 
early cases and none of the 12 recent cases 
undergoing pulmonary angioplasty have died 
from surgery. The causes of death were intra-
pleural hemorrhage in one patient and obst-
ruction of the pulmonary artery accompaning 
ruptured pulmonary cyst in another patient. 
The cause of death in patients who survived 
over 30 days after surgery were reccurent cancer 
in three patients (recurrence in the residual 
stump with metastasis to the lung in one pati-
ent, and pleural metastasis in two patients ), 
pyothorax in two patients and heart failure in 
one patient. 
         COMMENT 
 Bronchoplastic procedures for lung cancer is 
an alternative pneumonectomy. Weisel and 
coworkers reported no defference in the actual 
survival of the patients undergoing sleeve 
lobectomy compared with a. group of patients 
receiving pneumonectomy. In our previous
study the patients undergoing bronchoplastic 
procedures for lung cancer had better prognosis 
than the patients receiving pneumonectomy, 
and revealed similar prognosis as the patients 
undergoing a conventional lobectomy for 
bronchogenic carcinoma. 
 The survival data tabulated by Lowe and 
colleagues for all series reported in the litera-
ture revealed five-year survival rate of 3 3 % 
and 10-year survival rate of 21%. Our entire 
series had a five-year survival rate of 24%, 
which was not necessarily fevarable data than 
that of the literature. The reason can be con-
sidered that most of our patients had Stage III 
disease when compared with the cases previous-
ly reported in the literature. 
 Faber and colleagues reported that 5 9 
patients (58.4%) with Stage I bronchogenic 
carcinoma revealed five-year survival rate of 
36%. The probability of surviving five years in 
the stage II patients was 18% and that in the 
stage III patients, 15%. Our data are similar 
as stage I disease revealed five-year survival 
rate of 46.79/o, Stage II cancer, 27.8%, and 
Stage III cancer 26.1%. 
 It seems that Stage I patients have improved 
survival compared with Stage III patients. 
Faber emphasized that positive lobar or media-
stinal nodes identified at the tune of the opera-
tion do not contraindicate bronchoplastic pro-
cedures for bronchogenic carcinoma. Five-year 
survival rate of 18.4% in patients with positive 
nodes and of 26.1% of Stage III patients indi-
cates that bronchoplasty can be a satisfactory 
procedure when the disease is advanced. The 
majority of resected carcinomas were the squa-
mous cell type. Is was also included in 67.6Q'(') 
of our patients. 
 If the tumor or metastatic nodes extend to 
the pulmonary artery, an angioplasty should 
be considered. The blood flow of the pulmo-
nary artery is needed for nourishing the const-
ructed bronchus in which the bronchial arteries 
inevitably interrupted. Therefore, the surgeon 
must take care to avoid the stenosis or distor-
tion at the anastomosis of pulmonary artery. 
 In conclusion, bronchoplastic procedures with 
cnoncomitant purmonary angioplasty are a 
safe operation, if careful anastomosis and 
appropriate postoperative care were ensured.
The results were not inferior to those obtained 
by conducting bronchoplasty alone, as demon-
strated by our survival data. 
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